ICD-10-CM Billable Code

B37.89

Other sites of candidiasis

Clinical Classification Guidelines

Inclusion Terms

  • Candidal osteomyelitis

Medical Intelligence & Overview

Candidiasis is a fungal infection caused by a type of yeast called Candida. While many people associate Candida infections with the mouth or genital areas, it can actually affect various parts of the body. The ICD-10 code B37.89 refers to 'Other sites of candidiasis,' indicating infections occurring in less common locations. Such infections can sometimes become more serious, especially when they involve deep tissues like bones, leading to conditions such as candidal osteomyelitis. Recognizing where candidiasis can develop and understanding its implications is important for proper diagnosis and management.

Causes & Symptoms

Clinical Causes: Overgrowth of Candida yeast due to weakened immune system Use of broad-spectrum antibiotics that disrupt normal flora Chronic illnesses such as diabetes or HIV/AIDS Prolonged usage of corticosteroids or immunosuppressive therapies Presence of implanted medical devices like catheters or prostheses Poor hygiene or skin barrier breakdown Invasive medical procedures or surgeries that breach normal barriers

Key Symptoms: Localized redness, swelling, or pain in the affected site Presence of pus or discharge Unusual tissue swelling or induration Persistent or recurrent infections in the same location In cases of deep tissue involvement, such as osteomyelitis, symptoms may include: Deep bone pain Fever and malaise Reduced mobility or function of the affected limb or region Signs of systemic infection in severe cases

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a combination of clinical examination, laboratory tests, and imaging studies. Physicians may obtain samples from the affected site for microscopic examination and culture to identify Candida. Imaging modalities such as X-rays, MRI, or CT scans help determine the extent of tissue or bone involvement, especially in cases like osteomyelitis. Blood tests may reveal signs of systemic infection or immune status. Accurate diagnosis is essential for appropriate treatment planning.

Treatment Protocols: Managing candidiasis in uncommon locations involves antifungal medications tailored to the site and severity of infection. Common treatment options include: - Systemic antifungal drugs like fluconazole, itraconazole, or amphotericin B for deep or invasive infections - Surgical intervention to drain abscesses or remove infected tissue in severe cases - Supportive care to address underlying risk factors, such as controlling blood sugar levels or reducing immunosuppressive therapy - Close monitoring to assess response and prevent recurrence Early and appropriate management is key to preventing complications, especially in deep tissue infections like osteomyelitis.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is B37.89 a billable ICD-10 code?
Yes, B37.89 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report B37.89?
Clinical documentation must specify the nature of Other sites of candidiasis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

candidiasis